Isthmus Partners LLC grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 2.9% during the second quarter, HoldingsChannel reports. The firm owned 17,093 shares of the medical instruments supplier’s stock after buying an additional 478 shares during the period. Isthmus Partners LLC’s holdings in Utah Medical Products were worth $1,454,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV bought a new stake in shares of Utah Medical Products in the 1st quarter valued at $830,000. The Manufacturers Life Insurance Company bought a new stake in shares of Utah Medical Products in the 1st quarter valued at $213,000. Geode Capital Management LLC boosted its stake in shares of Utah Medical Products by 1.5% in the 1st quarter. Geode Capital Management LLC now owns 53,922 shares of the medical instruments supplier’s stock valued at $4,669,000 after purchasing an additional 793 shares during the last quarter. Jane Street Group LLC bought a new position in Utah Medical Products during the first quarter worth $200,000. Finally, Franklin Resources Inc. bought a new position in Utah Medical Products during the first quarter worth $1,340,000. 71.40% of the stock is currently owned by institutional investors.
Separately, TheStreet raised shares of Utah Medical Products from a “c+” rating to a “b-” rating in a research note on Tuesday, July 27th.
Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, July 22nd. The medical instruments supplier reported $0.94 earnings per share for the quarter. Utah Medical Products had a net margin of 27.78% and a return on equity of 12.38%. The firm had revenue of $12.60 million for the quarter.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 5th. Shareholders of record on Thursday, September 16th will be issued a dividend of $0.285 per share. The ex-dividend date is Wednesday, September 15th. This represents a $1.14 annualized dividend and a yield of 1.25%.
In other Utah Medical Products news, Director Barbara A. Payne sold 1,000 shares of the company’s stock in a transaction on Monday, August 30th. The shares were sold at an average price of $88.47, for a total transaction of $88,470.00. Following the transaction, the director now owns 10,838 shares in the company, valued at $958,837.86. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In the last 90 days, insiders have sold 2,000 shares of company stock worth $176,470. Corporate insiders own 7.00% of the company’s stock.
About Utah Medical Products
Utah Medical Products, Inc engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology.
Featured Article: What are the disadvantages of after-hours trading?
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.